Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Liqun Yu(Baylor College of Medicine), Keziah Liebenberg(Baylor College of Medicine), Yichao Shen(Baylor College of Medicine), Fengshuo Liu(Baylor College of Medicine), Zhan Xu(Baylor College of Medicine), Xiaoxin Hao(Baylor College of Medicine), Ling Wu(Baylor College of Medicine), Weijie Zhang(Baylor College of Medicine), Hilda L. Chan(Baylor College of Medicine), Bo Wei(The University of Texas MD Anderson Cancer Center), Philip L. Lorenzi(The University of Texas MD Anderson Cancer Center), Yang Gao(Baylor College of Medicine), Igor Bado(Baylor College of Medicine), Luis Becerra-Dominguez(Baylor College of Medicine), Charlotte Helena Rivas(Baylor College of Medicine), Sergio Aguirre(Baylor College of Medicine), Bradley C. Pingel(Baylor College of Medicine), Yi-Hsuan Wu(Baylor College of Medicine), Yunfeng Ding(Baylor College of Medicine), Jun Liu(Baylor College of Medicine), David G. Edwards(Baylor College of Medicine), Lívia S. Eberlin(Baylor College of Medicine), Xiang H.-F. Zhang(Baylor College of Medicine)
Cited by 58Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis